Treatment with L. acidophilus NX2-6 can promote glucose uptake, glycolysis, and intestinal gluconeogenesis, inhibit liver gluconeogenesis, and ameliorate HFD-induced glucose metabolism disorder by activating insulin signaling pathway. This evidence concerns the gene INS and glucose metabolism disease.